secwatch.observer — SEC 8-K summary
======================================

Issuer:     BOSTON SCIENTIFIC CORP (BSX)
CIK:        0000885725
Form:       8-K
Filed at:   2025-01-16T23:59:59+00:00
Accession:  0000885725-25-000003
Event type: litigation
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Boston Scientific reaches preliminary settlement of derivative lawsuits over LOTUS Edge recall
--------------------------------------------------------------------------------

- On January 8, 2025, a U.S. district court granted preliminary approval of a settlement of two shareholder derivative actions related to the LOTUS Edge recall.
- The proposed settlement, dated September 6, 2024, includes corporate governance reforms such as amendments to committee charters and insider trading policy.
- A final approval hearing is scheduled for March 25, 2025 at 2:00 p.m. Eastern Time.
- The derivative lawsuits alleged breaches of fiduciary duty and violations related to the prior recall and retirement of the LOTUS Edge Aortic Valve System.
- Under the settlement, Boston Scientific will adopt governance reforms to remain in effect for at least three years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885725/000088572525000003/0000885725-25-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885725/000088572525000003/bsx-20250116.htm
  HTML page:      https://secwatch.observer/filing/0000885725-25-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer